ENTRY       D00196                      Drug
NAME        Physostigmine (USP);
            Eserine (TN)
FORMULA     C15H21N3O2
EXACT_MASS  275.1634
MOL_WEIGHT  275.3461
SOURCE      Physostigma venenosum [TAX:271807]
CLASS       Neuropsychiatric agent
             DG01595  Cholinesterase inhibitor
              DG01593  Acetylcholinesterase inhibitor
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      Same as: C06535
            ATC code: S01EB05 V03AB19
            Chemical structure group: DG01132
EFFICACY    Acetylcholinesterase inhibitor (ophthalmic)
COMMENT     Reversible cholinesterase inhibitor
TARGET      ACHE [HSA:43] [KO:K01049]
  PATHWAY   hsa04725(43)  Cholinergic synapse
INTERACTION  
STR_MAP     map07056  Agents for Alzheimer-type dementia
            map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EB Parasympathomimetics
                 S01EB05 Physostigmine
                  D00196  Physostigmine (USP)
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AB Antidotes
                 V03AB19 Physostigmine
                  D00196  Physostigmine (USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG01132  Physostigmine
                 D00196  Physostigmine
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG01132  Physostigmine
                D00196  Physostigmine
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                ACHE
                 D00196  Physostigmine (USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01595  Cholinesterase inhibitor
               DG01593  Acetylcholinesterase inhibitor
                DG01132  Physostigmine
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG01132  Physostigmine
DBLINKS     CAS: 57-47-6
            PubChem: 7847264
            ChEBI: 27953
            LigandBox: D00196
            NIKKAJI: J4.579I
ATOM        20
            1   C1z C    26.2112  -14.1214
            2   C8y C    24.9526  -14.5409
            3   C1y C    27.0503  -15.2402
            4   C1x C    27.0503  -12.9326
            5   C1a C    25.3721  -13.0026
            6   C8y C    24.9526  -15.9395
            7   C8x C    23.6939  -13.8417
            8   N1y N    26.2112  -16.3591
            9   N1y N    28.3789  -14.8206
            10  C1x C    28.3789  -13.3522
            11  C8x C    23.6939  -16.6388
            12  C8y C    22.4353  -14.5409
            13  C1a C    26.6308  -17.6877
            14  C8x C    22.4353  -15.9395
            15  O7a O    21.2465  -13.8417
            16  C7a C    20.0578  -14.5409
            17  N1b N    18.8690  -13.8417
            18  O6a O    20.0578  -15.9395
            19  C1a C    17.6103  -14.5409
            20  C1a C    29.4977  -15.5899
BOND        22
            1    16  17 1
            2    16  18 2
            3    17  19 1
            4     6   8 1
            5     9  10 1
            6    12  14 1
            7     1   2 1
            8     1   3 1
            9     1   4 1
            10    1   5 1 #Up
            11    2   6 2
            12    2   7 1
            13    3   8 1
            14    3   9 1
            15    4  10 1
            16    6  11 1
            17    7  12 2
            18    8  13 1
            19   11  14 2
            20   12  15 1
            21   15  16 1
            22    9  20 1
///
